BenevolentAI

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

AnswerTime is an AI-led research tool that leverages artificial intelligence to provide quick and accurate answers to a wide range of research questions. The platform is designed to assist users in finding relevant information efficiently, saving time and effort in the research process. AnswerTime utilizes advanced algorithms to analyze and process data from various sources, delivering reliable results in a matter of seconds. With its user-friendly interface and powerful AI capabilities, AnswerTime is a valuable tool for students, professionals, and researchers seeking to enhance their research productivity.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Google Research is a team of scientists and engineers working on a wide range of topics in computer science, including artificial intelligence, machine learning, and quantum computing. Our mission is to advance the state of the art in these fields and to develop new technologies that can benefit society. We publish hundreds of research papers each year and collaborate with researchers from around the world. Our work has led to the development of many new products and services, including Google Search, Google Translate, and Google Maps.

Structurepedia is an AI-powered platform that maps the structure of knowledge by providing structured and interactive information on various topics, including neural network architecture variants and other important concepts in machine learning and artificial intelligence. It offers a new way to learn by allowing users to explore topics through visual diagrams and detailed resources, making it easier to understand complex information. Structurepedia aims to revolutionize the way people access and comprehend knowledge in the age of AI, acting as a modern encyclopedia and search engine tailored for the AI era.

Gradient Insight is a data science consulting and AI solutions provider. They offer a range of services including generative AI development, machine learning, computer vision, robotics and automation, AI strategy and roadmap, and data analytics. Their team of expert data scientists helps businesses to de-risk their investment in AI and to overcome barriers to engineering innovation. Gradient Insight has worked with clients such as Opitas, a fintech company, and the UK MOD. They offer a smooth and efficient process from consultation to delivery, and ongoing support and improvement.

STELLARWITS is an AI solutions and software platform that empowers users to explore cutting-edge technology and innovation. The platform offers AI models with versatile capabilities, ranging from content generation to data analysis to problem-solving. Users can engage directly with the technology, experiencing its power in real-time. With a focus on transforming ideas into technology, STELLARWITS provides tailored solutions in software and AI development, delivering intelligent systems and machine learning models for innovative and efficient solutions. The platform also features a download hub with a curated selection of solutions to enhance the digital experience. Through blogs and company information, users can delve deeper into the narrative of STELLARWITS, exploring its mission, vision, and commitment to reshaping the tech landscape.

Genesis Therapeutics is a cutting-edge platform that leverages molecular AI technology to discover and develop innovative medicines with exceptional potency and selectivity. The platform, known as GEMS (Generative AI for Drug Discovery), combines AI and physics research to identify drug candidates against challenging targets at an accelerated pace. The company's approach involves designing highly potent and selective drugs for chemically complex targets, driven by a team of collaborative minds across AI and biotech disciplines. Genesis Therapeutics is dedicated to advancing breakthrough medicines and bringing new hope to patients through its unique blend of technology and expertise.

Semantic Scholar is a free, AI-powered research tool for scientific literature. It is based at the Allen Institute for AI and provides access to over 217 million papers from all fields of science. Semantic Scholar uses AI to help users discover and explore scientific literature, and to stay up-to-date on the latest research. The tool also includes a number of features to help users manage their research, such as the ability to save papers, create bibliographies, and share research with others.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

ConsoleX is an advanced AI tool that offers a wide range of functionalities to unlock infinite possibilities in the field of artificial intelligence. It provides users with a powerful platform to develop, test, and deploy AI models with ease. With cutting-edge features and intuitive interface, ConsoleX is designed to cater to the needs of both beginners and experts in the AI domain. Whether you are a data scientist, researcher, or developer, ConsoleX empowers you to explore the full potential of AI technology and drive innovation in your projects.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

NVIDIA is a world leader in artificial intelligence computing. The company's products and services are used by businesses and governments around the world to develop and deploy AI applications. NVIDIA's AI platform includes hardware, software, and tools that make it easy to build and train AI models. The company also offers a range of cloud-based AI services that make it easy to deploy and manage AI applications. NVIDIA's AI platform is used in a wide variety of industries, including healthcare, manufacturing, retail, and transportation. The company's AI technology is helping to improve the efficiency and accuracy of a wide range of tasks, from medical diagnosis to product design.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

PubCompare is a powerful AI-powered tool that helps scientists search, compare, and evaluate experimental protocols. With over 40 million protocols in its database, PubCompare is the largest repository of trusted experimental protocols. PubCompare's AI-powered search features allow users to find similar protocols, highlight critical steps, and evaluate the reproducibility of protocols based on in-protocol citations. PubCompare is available from any computer and requires no download.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers solutions to accelerate trial timelines, enhance decision-making with digital twins, and identify sensitive clinical outcomes. The platform provides unparalleled precision in predicting clinical outcomes and is designed to put the power of AI in the hands of users. Unlearn.ai, Inc. focuses on accelerating clinical development in various medical fields through innovative AI technologies.

Abridge is an enterprise-grade AI platform for clinical conversations that transforms patient-clinician conversations into structured clinical notes in real-time. It saves hours of time-consuming documentation per clinician every month, provides clinically accurate summaries and medical terms across specialties, recognizes and takes accurate notes across a wide range of languages, and creates complete, highly accurate, structured clinical note drafts. Abridge is integrated directly inside Epic, allowing clinicians to harness its power without leaving the platform. The application aims to return time to teams, clarity to patients, and efficiencies to healthcare systems, ultimately reducing burnout and improving overall healthcare experiences.

Ubie is a medical AI application that offers a symptom checker and helps users find possible causes for their symptoms. Developed by doctors, Ubie's AI-powered system generates personalized reports on potential health issues based on a user's symptoms and personal information. The application aims to provide quick and accurate health information to users, guiding them on when to see a doctor, what might be causing their symptoms, and treatment information. Ubie values quality and safety, continuously improving its AI in collaboration with medical professionals worldwide.

RejuveAI is a decentralized token-based system that aims to democratize longevity globally. The Longevity App allows users to monitor essential health metrics, enhance lifespan, and earn RJV tokens. The application leverages revolutionary AI technology for human body analysis, collaborating with researchers, clinics, and data enthusiasts to combat aging. By harnessing sophisticated AI models and neural nets, Bayesian nets, simulations, and the AGI engine, RejuveAI targets in-depth representation of living systems. The platform offers exclusive discounts on travel, supplements, medical tests, and longevity therapies, making innovative outcomes affordable and accessible.

PMcardio is an AI-powered platform that offers accurate and rapid diagnosis of cardiovascular diseases through ECG interpretation. It provides healthcare professionals with advanced AI technology to detect conditions such as acute ST-elevation myocardial infarction (STEMI) and reduced Left Ventricular Ejection Fraction (LVEF) within seconds. PMcardio aims to streamline clinical decision-making, enhance diagnostic accuracy, and improve patient care by leveraging AI algorithms trained on millions of patient outcomes. The platform is designed to ensure standardized ECG reports, facilitate care coordination, and meet the highest standards of quality and security in healthcare settings.

Glass Health is an AI-powered clinical decision support platform that empowers clinicians by providing tools to develop differential diagnoses and draft clinical plans. The platform combines cutting-edge AI technology with evidence-based medical knowledge to streamline diagnostic decisions and optimize clinician workflows. Glass Health's mission is to leverage technology to enhance the practice of medicine, increase diagnostic accuracy, implement evidence-based medicine, promote health equity, and improve patient outcomes globally. The platform is built by clinicians, for clinicians, with a deep commitment to safety, ethics, and alignment.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Oncora Medical is a healthcare technology company that provides software and data solutions to oncologists and cancer centers. Their products are designed to improve patient care, reduce clinician burnout, and accelerate clinical discoveries. Oncora's flagship product, Oncora Patient Care, is a modern, intelligent user interface for oncologists that simplifies workflow, reduces documentation burden, and optimizes treatment decision making. Oncora Analytics is an adaptive visual and backend software platform for regulatory-grade real world data analytics. Oncora Registry is a platform to capture and report quality data, treatment data, and outcomes data in the oncology space.

The National Cancer Institute's Center for Biomedical Informatics and Information Technology (CBIIT) provides a comprehensive suite of tools, resources, and training to support cancer data science research. These resources include data repositories, analytical tools, data standards, and training materials. CBIIT also develops and maintains the NCI Thesaurus, a comprehensive vocabulary of cancer-related terms, and the Cancer Data Standards Registry and Repository (caDSR), a repository of cancer data standards. CBIIT's mission is to accelerate the pace of cancer research by providing researchers with the tools and resources they need to access, analyze, and share cancer data.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

Sully.ai is the #1 all-in-one AI solution designed to save doctors' time by creating superhuman doctors. The platform offers a comprehensive set of features such as pre-visit screening, decision support, scribing, diagnosis assistance, clinical planning, and post-visit automations. Sully.ai is an automation platform that works seamlessly with Electronic Medical Records (EMR) systems, providing personalized and multilingual support for healthcare professionals. The AI model is HIPAA compliant and trained on real-life doctor encounters to enhance decision-making and streamline administrative tasks. With proven results in reducing repetitive tasks and improving efficiency, Sully.ai aims to transform healthcare delivery by empowering doctors to focus on patient care.